 | • レポートコード：MRC2012B0262 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、診断用バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。診断用バイオマーカーの種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（病院、がん研究所、診断研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Qiagen N.V.、Biosims Technologies Sas、Bio-Rad Laboratories, Inc.、Perkinelmer, Inc.、Meso Scale Diagnostics, LLC.、Merck Millipore、Signosis, Inc、EKF Diagnostics Holdings, Inc.、Enzo Biochem, Inc.、Cisbio Bioassays、Banyan Biomarkers, Inc、Biomedical Corp、 ・地域別グローバル市場分析 2015年-2020年 ・診断用バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・診断用バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・診断用バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・診断用バイオマーカーの南米市場（ブラジル、アルゼンチン） ・診断用バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー ・用途別分析：病院、がん研究所、診断研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Diagnostic Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Diagnostic Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diagnostic Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diagnostic Biomarkers market has been segmented into:
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
By Application, Diagnostic Biomarkers has been segmented into:
Hospitals
Cancer Research Institutes
Diagnostic Labs
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Diagnostic Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diagnostic Biomarkers Market Share Analysis
Diagnostic Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Diagnostic Biomarkers are:
Qiagen N.V.
Biosims Technologies Sas
Bio-Rad Laboratories, Inc.
Perkinelmer, Inc.
Meso Scale Diagnostics, LLC.
Merck Millipore
Signosis, Inc
EKF Diagnostics Holdings, Inc.
Enzo Biochem, Inc.
Cisbio Bioassays
Banyan Biomarkers, Inc
Biomedical Corp
Table of Contents
1 Diagnostic Biomarkers Market Overview
1.1 Product Overview and Scope of Diagnostic Biomarkers
1.2 Classification of Diagnostic Biomarkers by Type
1.2.1 Global Diagnostic Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnostic Biomarkers Revenue Market Share by Type in 2019
1.2.3 Safety Biomarkers
1.2.4 Efficacy Biomarkers
1.2.5 Validation Biomarkers
1.3 Global Diagnostic Biomarkers Market by Application
1.3.1 Overview: Global Diagnostic Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Global Diagnostic Biomarkers Market by Regions
1.4.1 Global Diagnostic Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnostic Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnostic Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Qiagen N.V. SWOT Analysis
2.1.4 Qiagen N.V. Product and Services
2.1.5 Qiagen N.V. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biosims Technologies Sas
2.2.1 Biosims Technologies Sas Details
2.2.2 Biosims Technologies Sas Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biosims Technologies Sas SWOT Analysis
2.2.4 Biosims Technologies Sas Product and Services
2.2.5 Biosims Technologies Sas Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bio-Rad Laboratories, Inc.
2.3.1 Bio-Rad Laboratories, Inc. Details
2.3.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.3.4 Bio-Rad Laboratories, Inc. Product and Services
2.3.5 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Perkinelmer, Inc.
2.4.1 Perkinelmer, Inc. Details
2.4.2 Perkinelmer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Perkinelmer, Inc. SWOT Analysis
2.4.4 Perkinelmer, Inc. Product and Services
2.4.5 Perkinelmer, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Meso Scale Diagnostics, LLC.
2.5.1 Meso Scale Diagnostics, LLC. Details
2.5.2 Meso Scale Diagnostics, LLC. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Meso Scale Diagnostics, LLC. SWOT Analysis
2.5.4 Meso Scale Diagnostics, LLC. Product and Services
2.5.5 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck Millipore
2.6.1 Merck Millipore Details
2.6.2 Merck Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Millipore SWOT Analysis
2.6.4 Merck Millipore Product and Services
2.6.5 Merck Millipore Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Signosis, Inc
2.7.1 Signosis, Inc Details
2.7.2 Signosis, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Signosis, Inc SWOT Analysis
2.7.4 Signosis, Inc Product and Services
2.7.5 Signosis, Inc Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 EKF Diagnostics Holdings, Inc.
2.8.1 EKF Diagnostics Holdings, Inc. Details
2.8.2 EKF Diagnostics Holdings, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 EKF Diagnostics Holdings, Inc. SWOT Analysis
2.8.4 EKF Diagnostics Holdings, Inc. Product and Services
2.8.5 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 Enzo Biochem, Inc.
2.9.1 Enzo Biochem, Inc. Details
2.9.2 Enzo Biochem, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Enzo Biochem, Inc. SWOT Analysis
2.9.4 Enzo Biochem, Inc. Product and Services
2.9.5 Enzo Biochem, Inc. Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cisbio Bioassays
2.10.1 Cisbio Bioassays Details
2.10.2 Cisbio Bioassays Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cisbio Bioassays SWOT Analysis
2.10.4 Cisbio Bioassays Product and Services
2.10.5 Cisbio Bioassays Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.11 Banyan Biomarkers, Inc
2.11.1 Banyan Biomarkers, Inc Details
2.11.2 Banyan Biomarkers, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Banyan Biomarkers, Inc SWOT Analysis
2.11.4 Banyan Biomarkers, Inc Product and Services
2.11.5 Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biomedical Corp
2.12.1 Biomedical Corp Details
2.12.2 Biomedical Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biomedical Corp SWOT Analysis
2.12.4 Biomedical Corp Product and Services
2.12.5 Biomedical Corp Diagnostic Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnostic Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Biomarkers Players Market Share
3.2.2 Top 10 Diagnostic Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnostic Biomarkers Revenue and Market Share by Regions
4.2 North America Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Diagnostic Biomarkers Revenue by Countries
5.1 North America Diagnostic Biomarkers Revenue by Countries (2015-2020)
5.2 USA Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Diagnostic Biomarkers Revenue by Countries
6.1 Europe Diagnostic Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnostic Biomarkers Revenue by Countries
7.1 Asia-Pacific Diagnostic Biomarkers Revenue by Countries (2015-2020)
7.2 China Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Diagnostic Biomarkers Revenue by Countries
8.1 South America Diagnostic Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnostic Biomarkers by Countries
9.1 Middle East & Africa Diagnostic Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnostic Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnostic Biomarkers Market Forecast by Type (2019-2024)
10.3 Safety Biomarkers Revenue Growth Rate (2015-2025)
10.4 Efficacy Biomarkers Revenue Growth Rate (2015-2025)
10.5 Validation Biomarkers Revenue Growth Rate (2015-2025)
11 Global Diagnostic Biomarkers Market Segment by Application
11.1 Global Diagnostic Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Diagnostic Biomarkers Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Cancer Research Institutes Revenue Growth (2015-2020)
11.5 Diagnostic Labs Revenue Growth (2015-2020)
12 Global Diagnostic Biomarkers Market Size Forecast (2021-2025)
12.1 Global Diagnostic Biomarkers Market Size Forecast (2021-2025)
12.2 Global Diagnostic Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diagnostic Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnostic Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Qiagen N.V. Corporate Information, Location and Competitors
Table 6. Qiagen N.V. Diagnostic Biomarkers Major Business
Table 7. Qiagen N.V. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 8. Qiagen N.V. SWOT Analysis
Table 9. Qiagen N.V. Diagnostic Biomarkers Product and Solutions
Table 10. Qiagen N.V. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biosims Technologies Sas Corporate Information, Location and Competitors
Table 12. Biosims Technologies Sas Diagnostic Biomarkers Major Business
Table 13. Biosims Technologies Sas Diagnostic Biomarkers Total Revenue (USD Million) (2018-2019)
Table 14. Biosims Technologies Sas SWOT Analysis
Table 15. Biosims Technologies Sas Diagnostic Biomarkers Product and Solutions
Table 16. Biosims Technologies Sas Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 18. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Major Business
Table 19. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 20. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 21. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product and Solutions
Table 22. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Perkinelmer, Inc. Corporate Information, Location and Competitors
Table 24. Perkinelmer, Inc. Diagnostic Biomarkers Major Business
Table 25. Perkinelmer, Inc. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 26. Perkinelmer, Inc. SWOT Analysis
Table 27. Perkinelmer, Inc. Diagnostic Biomarkers Product and Solutions
Table 28. Perkinelmer, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Meso Scale Diagnostics, LLC. Corporate Information, Location and Competitors
Table 30. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Major Business
Table 31. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 32. Meso Scale Diagnostics, LLC. SWOT Analysis
Table 33. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product and Solutions
Table 34. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Millipore Corporate Information, Location and Competitors
Table 36. Merck Millipore Diagnostic Biomarkers Major Business
Table 37. Merck Millipore Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 38. Merck Millipore SWOT Analysis
Table 39. Merck Millipore Diagnostic Biomarkers Product and Solutions
Table 40. Merck Millipore Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Signosis, Inc Corporate Information, Location and Competitors
Table 42. Signosis, Inc Diagnostic Biomarkers Major Business
Table 43. Signosis, Inc Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 44. Signosis, Inc SWOT Analysis
Table 45. Signosis, Inc Diagnostic Biomarkers Product and Solutions
Table 46. Signosis, Inc Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. EKF Diagnostics Holdings, Inc. Corporate Information, Location and Competitors
Table 48. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Major Business
Table 49. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 50. EKF Diagnostics Holdings, Inc. SWOT Analysis
Table 51. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product and Solutions
Table 52. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Enzo Biochem, Inc. Corporate Information, Location and Competitors
Table 54. Enzo Biochem, Inc. Diagnostic Biomarkers Major Business
Table 55. Enzo Biochem, Inc. Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 56. Enzo Biochem, Inc. SWOT Analysis
Table 57. Enzo Biochem, Inc. Diagnostic Biomarkers Product and Solutions
Table 58. Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cisbio Bioassays Corporate Information, Location and Competitors
Table 60. Cisbio Bioassays Diagnostic Biomarkers Major Business
Table 61. Cisbio Bioassays Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 62. Cisbio Bioassays SWOT Analysis
Table 63. Cisbio Bioassays Diagnostic Biomarkers Product and Solutions
Table 64. Cisbio Bioassays Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Banyan Biomarkers, Inc Corporate Information, Location and Competitors
Table 66. Banyan Biomarkers, Inc Diagnostic Biomarkers Major Business
Table 67. Banyan Biomarkers, Inc Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 68. Banyan Biomarkers, Inc SWOT Analysis
Table 69. Banyan Biomarkers, Inc Diagnostic Biomarkers Product and Solutions
Table 70. Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Biomedical Corp Corporate Information, Location and Competitors
Table 72. Biomedical Corp Diagnostic Biomarkers Major Business
Table 73. Biomedical Corp Diagnostic Biomarkers Total Revenue (USD Million) (2017-2018)
Table 74. Biomedical Corp SWOT Analysis
Table 75. Biomedical Corp Diagnostic Biomarkers Product and Solutions
Table 76. Biomedical Corp Diagnostic Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Diagnostic Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 78. Global Diagnostic Biomarkers Revenue Share by Players (2015-2020)
Table 79. Global Diagnostic Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Diagnostic Biomarkers Revenue Market Share by Regions (2015-2020)
Table 81. North America Diagnostic Biomarkers Revenue by Countries (2015-2020)
Table 82. North America Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Table 83. Europe Diagnostic Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Diagnostic Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Diagnostic Biomarkers Revenue by Countries (2015-2020)
Table 86. South America Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Diagnostic Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Table 89. Global Diagnostic Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 90. Global Diagnostic Biomarkers Revenue Share by Type (2015-2020)
Table 91. Global Diagnostic Biomarkers Revenue Forecast by Type (2021-2025)
Table 92. Global Diagnostic Biomarkers Revenue by Application (2015-2020)
Table 93. Global Diagnostic Biomarkers Revenue Share by Application (2015-2020)
Table 94. Global Diagnostic Biomarkers Revenue Forecast by Application (2021-2025)
Table 95. Global Diagnostic Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diagnostic Biomarkers Picture
Figure 2. Global Diagnostic Biomarkers Revenue Market Share by Type in 2019
Figure 3. Safety Biomarkers Picture
Figure 4. Efficacy Biomarkers Picture
Figure 5. Validation Biomarkers Picture
Figure 6. Diagnostic Biomarkers Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Cancer Research Institutes Picture
Figure 9. Diagnostic Labs Picture
Figure 10. Global Diagnostic Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Diagnostic Biomarkers Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Diagnostic Biomarkers Revenue Market Share in 2019
Figure 19. Global Top 10 Players Diagnostic Biomarkers Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Diagnostic Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Diagnostic Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 23. Global Diagnostic Biomarkers Revenue Market Share by Regions in 2018
Figure 24. North America Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 25. Europe Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 27. South America Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. North America Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 30. North America Diagnostic Biomarkers Revenue Market Share by Countries in 2019
Figure 31. USA Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. Canada Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 34. Europe Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Diagnostic Biomarkers Revenue Market Share by Countries in 2019
Figure 36. Germany Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. UK Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. France Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 39. Russia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 40. Italy Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Diagnostic Biomarkers Revenue Market Share by Countries in 2019
Figure 43. China Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Japan Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Korea Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 46. India Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. South America Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 49. South America Diagnostic Biomarkers Revenue Market Share by Countries in 2019
Figure 50. Brazil Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Diagnostic Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Diagnostic Biomarkers Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. UAE Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Diagnostic Biomarkers Revenue and Growth Rate (2015-2020)
Figure 58. Global Diagnostic Biomarkers Revenue Share by Type (2015-2020)
Figure 59. Global Diagnostic Biomarkers Revenue Share by Type in 2019
Figure 60. Global Diagnostic Biomarkers Market Share Forecast by Type (2021-2025)
Figure 61. Global Safety Biomarkers Revenue Growth Rate (2015-2020)
Figure 62. Global Efficacy Biomarkers Revenue Growth Rate (2015-2020)
Figure 63. Global Validation Biomarkers Revenue Growth Rate (2015-2020)
Figure 64. Global Diagnostic Biomarkers Revenue Share by Application (2015-2020)
Figure 65. Global Diagnostic Biomarkers Revenue Share by Application in 2019
Figure 66. Global Diagnostic Biomarkers Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Cancer Research Institutes Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic Labs Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Diagnostic Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Diagnostic Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
Figure 74. Europe Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
Figure 76. South America Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Diagnostic Biomarkers Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…- ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- EPOバイオマーカーの世界市場（～2026年） Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Major factors contributing to the growth of the global EPO biomarkers market include increasing sede…
- 心臓バイオマーカーの世界市場（～2026年） Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These …
- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…